CMPX
NASDAQ · Biotechnology
Compass Therapeutics Inc
$5.44
+0.11 (+2.06%)
Open$5.42
Previous Close$5.33
Day High$5.49
Day Low$5.39
52W High$6.88
52W Low$1.33
Volume—
Avg Volume2.42M
Market Cap983.58M
P/E Ratio—
EPS$-0.34
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
+888.4% upside
Current
$5.44
$5.44
Target
$53.77
$53.77
$36.32
$53.77 avg
$66.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.15M | 182.11M | 191.80M |
| Net Income | -66,446,946 | -42,646,254 | -48,286,720 |
| Profit Margin | -5,808.8% | -23.4% | -25.2% |
| EBITDA | -75,469,235 | -49,107,977 | -55,425,546 |
| Free Cash Flow | — | -37,978,554 | -43,960,363 |
| Rev Growth | — | -8.0% | +10.9% |
| Debt/Equity | — | 0.29 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |